Notice 6 Mar 2025 compliance, drug enforcement, business regulations, pharmaceutical, controlled substances, dea

💊DEA Notice for Aphena Pharma As Controlled Substances Importer

Aphena Pharma Solutions MD, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 26 Feb 2025 pharmaceutical industry, compliance, controlled substances, s&b pharma, drug enforcement, dea

💊Notice of S&B Pharma's Application for Controlled Substances Import

S&B Pharma LLC DBA Norac Pharma has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 26 Feb 2025 regulation, controlled substances, drug enforcement, pharmaceutical, business compliance

💊Catalent Pharma's Application for Controlled Substance Importing

Catalent Pharma Solutions, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Rule 19 Feb 2025 healthcare, veterans, regulation, telemedicine, buprenorphine, drug enforcement, opioid treatment

💊Telemedicine Regulation for Buprenorphine Treatment Updated

In the January 17, 2025, issue of the Federal Register, the Drug Enforcement Administration and the Department of Health and Human Services published two final rules related to the practice of telemedicine, titled "Expansion of Buprenorphine Treatment via Telemedicine Encounter" and "Continuity of Care via Telemedicine for Veterans Affairs Patients." These final rules were scheduled to become final on February 18, 2025. In accordance with the Presidential Memorandum of January 20, 2025, titled "Regulatory Freeze Pending Review," the Drug Enforcement Administration and the Department of Health and Human Services are delaying the effective dates of these two final rules to March 21, 2025, and are soliciting public comments specifically regarding this delayed effective date.

Learn More
Notice 18 Feb 2025 compliance, business regulation, research, pharmaceutical industry, controlled substances, drug enforcement

💊Notice of Application for Bulk Manufacturing of Controlled Substances

Scottsdale Research Institute, has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Learn More
Notice 18 Feb 2025 business compliance, pharmaceuticals, regulatory requirements, dea, controlled substances, drug enforcement, scottsdale research institute

💊Scottsdale Research Institute Seeks Registration for Controlled Substances

Scottsdale Research Institute has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Learn More
Notice 18 Feb 2025 compliance, regulations, pharmaceutical, controlled substances, drug enforcement, patheon api inc.

💊Patheon API Inc. Seeks Registration as Bulk Manufacturer of Controlled Substances

Patheon API Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Learn More
Notice 14 Feb 2025 compliance, healthcare, medical regulation, colorado, dea, drug enforcement

⚖️DEA Revokes Yogesh Patel, M.D.'s Registration Due to Non-Compliance

The Drug Enforcement Administration issued an Order to Show Cause for the revocation of Yogesh Patel, M.D.'s DEA registration, citing that he lacks authority to handle controlled substances in Colorado. The decision results from his default to request a hearing following a prior suspension of his state medical license, emphasizing the importance of maintaining proper licensure for medical practitioners.

Learn More
Notice 13 Feb 2025 regulatory compliance, dea, pharmaceuticals, business application, drug enforcement, controlled substances

💊Benuvia Operations, LLC Application for Bulk Manufacturing License

Benuvia Operations, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 13 Feb 2025 imports, compliance, drug enforcement, controlled substances, regulation

💊Veranova, L.P. Seeks Registration as Controlled Substances Importer

Veranova, L.P. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Learn More